Intellectual Property Law360 provides breaking news and analysis on IP law. Coverage includes high-stakes cases involving patents, copyrights, trademarks, trade secrets, and other forms of IP, as well as policy developments and licensing deals.
A contract outlining terms of Cephalon Inc.’s $125 million settlement, which resolved allegations it paid competitors to delay generic versions of its Provigil drug, is binding and enforceable, a Pennsylvania federal judge said Friday, but left undetermined if an insurer-claimant’s attorneys were authorized to approval the deal.
With a trial looming, Dicerna Pharmaceuticals Inc. announced Friday it would shell out $15 million and close to a million shares of common stock to end Massachusetts state and federal court litigation with Alnylam Pharmaceuticals Inc. in which both sides accused the other of misappropriating trade secrets for technology related to RNA interference.
Three months after the full Federal Circuit gave Wi-Fi One LLC a chance to argue Broadcom Corp. was too late with its challenges to messaging patents at the Patent Trial and Appeal Board, a split panel of judges for the appeals court ruled the board correctly invalidated claims in the patents.
U.S. Patent and Trademark Office Director Andrei Iancu on Friday called for a "new narrative" about patents that emphasizes their benefit to society, illustrating his point in a speech at a lunch for women in intellectual property by highlighting the breakthrough inventions of Hollywood star Hedy Lamarr.
In Law360's latest roundup of new actions at the Trademark Trial and Appeal Board, Monster Energy Co. picks a fight with Cleveland's professional hockey team over a rebranded name, the New York Yankees and several other Major League Baseball teams launch new cases, and AARP gets angry about an acronym.